BioLineRx (BLRX) EPS (Basic) Growth (5y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | BioLineRx | 9.32 Bn | 9.30 Bn | 154,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 50.94% |
| Sep 30, 2025 | -0.77% |
| Jun 30, 2025 | 6.53% |
| Mar 31, 2025 | 7.70% |
| Dec 31, 2024 | 14.93% |
| Sep 30, 2024 | 37.88% |
| Jun 30, 2024 | -33.82% |
| Mar 31, 2024 | -16.25% |
| Dec 31, 2023 | 27.52% |
| Sep 30, 2023 | 19.73% |
| Jun 30, 2023 | 19.14% |
| Mar 31, 2023 | 30.12% |
| Dec 31, 2022 | 36.57% |
| Sep 30, 2022 | 32.24% |
| Jun 30, 2022 | 17.08% |
| Mar 31, 2022 | 34.02% |
| Dec 31, 2021 | 33.28% |
| Sep 30, 2021 | 34.02% |
| Jun 30, 2021 | 16.47% |
| Mar 31, 2021 | 19.73% |
| Dec 31, 2020 | 12.51% |
| Sep 30, 2020 | -53.28% |
| Jun 30, 2020 | 19.73% |
| Mar 31, 2020 | 16.91% |
| Dec 31, 2019 | -248.51% |
| Jun 30, 2019 | 18.47% |
| Mar 31, 2019 | -44.27% |
| Dec 31, 2018 | -20.11% |
| Sep 30, 2018 | -24.57% |
| Jun 30, 2018 | -20.11% |
| Mar 31, 2018 | -24.57% |